Breast Cancer Clinical Trials

Showing 3281-3300 of 5,597 trials

Augmented Reality (AR): The Future of "Patient Information Leaflets

NCT04619030

This project aims to assess a new type of Augmented Reality Patient Information leaflet, in order to demonstrate that it is a beneficial information resource to patients when facing the diagnosis of sarcoma, breast cancer or to explain difficult concepts such as cleft lip repair. There are no published studies on the use of AR in patient leaflets.

SarcomaBreast CancerCleft Lip and Palate+1 more

NHS Greater Glasgow and Clyde20 participantsStarted Nov 2020

Glasgow, Scotland, United Kingdom • Glasgow, Scotland, United Kingdom • Glasgow, Scotland, United Kingdom

COMPLETEDPhase 2

Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer

NCT00629616

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using anastrozole or fulvestrant may fight breast cancer by lowering the amount of estrogen the body makes or by blocking the use of estrogen by the tumor cells. Giving hormone therapy before surgery may be an effective treatment for breast cancer. It is not yet known whether anastrozole is more effective than fulvestrant when given before surgery in treating women with breast cancer. PURPOSE: This randomized phase II trial is studying anastrozole to see how well it works compared with fulvestrant in treating postmenopausal women with stage II or stage III breast cancer that can be removed by surgery.

Breast Cancer

UNICANCER116 participantsStarted Oct 2007

Clermont-Ferrand, France • Limoges, France • Paris, France +3 more locations

Augmented Reality (AR): The Future of "Patient Information Leaflets

Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer

Related Searches

Pre-operative Hypnosis to Prevent Side Effects After Surgery

Pilot Clinical Study on a Low-power Electromagnetic Wave Breast Imaging Device for Cancer Screening Purposes.

Tislelizumab in Combination With Eribulin for Patients With Metastatic Previously heaviLy-treAted TriplE-negative Breast Cancer：A Prospective Multiple-center Phase II Study

The BEACON Study (Breast Cancer Outcomes With NKTR-102)

Study of Camrelizumab Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)

Reverse Axillary Mapping in Breast Radiation Treatment Planning

Pyrotinib Versus Pertuzumab in Combination With Neoadjuvant Trastuzumab and Nab-Paclitaxel in HER2+ Early or Locally Advanced Breast Cancer

Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer

A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients With Palpable Cancers

Treatment With Pyrotinib-Based Therapy in Lapatinib Resistant HER2-Positive Metastatic Breast Cancer

Analgesic Effect of Adding Thoracic Paravertebral Nerve Blocks to Modified PEC Block in Breast Cancer Surgery

Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer

Development of a Patient Decision Aid for Women Considering Breast Reconstruction

Plasma Circulating Tumor DNA Analyses in ER+ Metastatic Breast Cancer

Intravenous Chemotherapy and Plant-based Dietary Supplements

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery

Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile

Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.